Key result
Multi-omics profiling of human left-ventricular tissue identified >10,000 significant eQTLs and 8,600 sQTLs, with 21 expression and 17 splicing loci colocalizing with dilated cardiomyopathy risk.
Why the study?
The regulatory molecular mechanisms that link genetic variation to cardiac dysfunction in heart failure remain elusive.
Observational (n=516)
Answers are grounded in this paper and cite their sources.
The TOPCHeF resource provides a foundational multi-omics dataset linking genetic variation to transcriptional and splicing mechanisms in the failing human heart.
Heart failure (HF) is a leading global cause of morbidity and mortality, yet the regulatory molecular mechanisms that link genetic variation to cardiac dysfunction remain elusive. To bridge this gap, we created the Trans-Omics for Precision Medicine in Congestive Heart Failure (TOPCHeF) resource, a multi-omics dataset comprising >700 human left-ventricular tissue samples, including dilated cardiomyopathy (DCM), ischemic cardiomyopathy (ICM), and non-failing controls, with paired whole-genome and RNA sequencing. By mapping expression-(eQTL) and splicing-(sQTL) quantitative trait loci directly in diseased human hearts, we identified over 10,000 transcripts with significant eQTL and 8,600 isoforms with significant sQTL, across both coding and non-coding genes, many of which overlap loci previously associated with HF and emerging novel gene associations. Single-locus colocalization with a largescale DCM genome-wide association study revealed 21 expression and 17 splicing-QTL that share causal variants with disease risk. These include known Mendelian cardiomyopathy risk genes such as FLNC and ACTN2 , and novel regulatory candidates like CAMK2D , LMF1 , MYOZ1 , SKI , SYNPO2L , and TKT . Several loci also showed coordinated effects on both gene expression and RNA splicing, implicating calcium signaling, cytoskeletal organization, and metabolic pathways in HF pathogenesis. Together, these results help define the regulatory landscape of the failing human heart and establish TOPCHeF as a foundational resource for connecting genetic variation to transcriptional and splicing molecular mechanisms in HF research.
No takes yet. Share an insight, caveat, or question.
Murray et al. (2026) conducted an observational in Heart failure (Dilated and Ischemic Cardiomyopathy) (n=516). Multi-omics profiling (WGS and RNA-seq) vs. Non-failing controls was evaluated on Significant expression (eQTL) and splicing (sQTL) quantitative trait loci. Multi-omics profiling of human left-ventricular tissue identified >10,000 significant eQTLs and 8,600 sQTLs, with 21 expression and 17 splicing loci colocalizing with dilated cardiomyopathy risk.
Synapse has enriched 10 related papers. Consider them for comparative context: